Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Higgins

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Scientific Reports|August 21, 2019
Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancyRatna Veeramachaneni, Thomas Walker, Timothée Revil, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Scientific Reports|August 21, 2019
Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancyRatna Veeramachaneni, Thomas Walker, Timothée Revil, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Pageof 2